Home › Funds › Alyeska Investment Group, L.P. › BIIB
Alyeska Investment Group, L.P. position in BIIB
BIOGEN INC · Health Care
Alyeska Investment Group, L.P. reported holding 932,374 shares of BIIB (BIOGEN INC) in its Q2 2026 13F filing — a position valued at US$201.4M, representing 0.52% of its reported portfolio and ranking #37 among its reported holdings. Alyeska Investment Group, L.P. has disclosed BIIB holdings in 9 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Alyeska Investment Group, L.P.'s BIIB position evolved
Alyeska Investment Group, L.P. first disclosed a stake in BIIB in Q3 2023 at 442,076 shares (US$113.6M). The position peaked in Q2 2026 at 932,374 shares, worth US$201.4M. Across 9 filings, Alyeska Investment Group, L.P. increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 932,374 shares valued at US$201.4M — an increase of 127,324 shares quarter over quarter.. Notable position changes include a 61% trim in Q1 2024 (shares rose 8% over the following quarter), a 141% increase in Q2 2024 (shares fell 16% over the following quarter), a 66% increase in Q3 2025 (shares rose 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 442.08K | $113.62M | New |
| Q4 2023 | 422.68K | $109.38M | Reduce |
| Q1 2024 | 166.69K | $35.94M | Reduce |
| Q2 2024 | 401.00K | $92.96M | Add |
| Q2 2025 | 508.77K | $63.90M | New |
| Q3 2025 | 845.28K | $118.41M | Add |
| Q4 2025 | 1.02M | $180.26M | Add |
| Q1 2026 | 805.05K | $147.59M | Reduce |
| Q2 2026 | 932.37K | $201.45M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIIB and 13F data
BIIB (BIOGEN INC) is a Health Care company. 22 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIIB
- PRIMECAP MANAGEMENT CO/CA/ 15.15M sh · $3.27B · Q2 2026
More on Alyeska Investment Group, L.P.
FAQ
How long has Alyeska Investment Group, L.P. held BIIB?
Alyeska Investment Group, L.P. has disclosed BIIB holdings in 9 of the last 12 reported quarters, going back to Q3 2023.
What is Alyeska Investment Group, L.P.'s current position in BIIB?
As of Q2 2026, Alyeska Investment Group, L.P. holds 932.37K shares of BIIB (BIOGEN INC), valued at $201.45M, representing 0.52% of its reported portfolio and ranking #37.
Has Alyeska Investment Group, L.P. been buying or selling BIIB?
In the latest 13F filing (Q2 2026), Alyeska Investment Group, L.P. increased its position in BIIB. The position peaked in Q2 2026 at 932.37K shares.
Which other funds hold BIIB?
Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.